AnalysisNews

ASTH today

$32.53-$0.34 (-1.03%)close Nov 17, 2026

Trend

DailyDowntrend (confirmed)

4 hourExpanding

1 hourStrong Bullish

15 minStrong Bullish

5 minBearish

Daily trend turns up above $41.00

Key levels

Resistance$38.77

Resistance$35.65

Support$32.22

Support$29.33

Latest news & SEC filings

AnalystNeedham keeps Buy rating on Astrana Health, lifts target to $45

EarningsAstrana Health holds Q3 2026 earnings call

All ASTH news →

About Astrana Health

Astrana Health runs a medical care business built around physicians and technology, taking on financial risk for patient populations. Its operations fall into three segments: Care Partners, which organizes independent doctors and accountable care groups into risk-bearing networks; Care Delivery, which covers clinics, a hospital, imaging and surgery centers, labs, and a pharmacy; and Care Enablement, which supplies software and administrative support to doctors and insurers. Patients are mainly those with Medicare, Medicaid, commercial, or exchange coverage, and activities are concentrated in the United States.

Based on the company's 10-K filed Mar 12, 2026.

Nasdaq · Industrials

Astrana Health, Inc. (ASTH)

$32.87+1.07 (+3.36%)
WATCHLISTGrade: B+Risk: MEDIUM
1D5D1M1Y5YMaxSign up for all timeframes
33.3534.9336.5138.0932.87Oct 14Oct 22Oct 30Nov 9
High33.07
Low31.61
Open31.93
Volume426K
Avg Vol321K
VWAP32.61
30d High39.67
30d Low31.77
30d Chg-11.16%

What Is the Price Target for ASTH?

SEPT Low Target

$40.00

SEPT Mid Target

$51.50

SEPT High Target

$65.00

Analyst Consensus

$51.50

Current: $32.87Upside: +56.7%Confidence: 85%Method: Analyst Consensus

Is ASTH a Buy or Sell Right Now?

69
Investability Score
WATCHLIST12-18 months
News summary · last 30 days
Critical news
Nov 5HIGHEarnings: growth/beat

Thesis

  • •Revenue growing 56.4% YoY with ACCELERATING trend — accelerating momentum.

Test your own strategy on ASTH

Describe your strategy in plain words, then scan, alert, backtest and paper trade it on ASTH with SEPT’s own market data.

Start Free Trial →

Is ASTH Overvalued or Undervalued?

Valuation Verdict

FAIR

Methods Used

P/E Forward, P/B, Analyst Consensus

Fair Value

$47.94

23

Moat Score

NONE

3/9

Piotroski Score

2.5

Altman Z-Score

What Is Smart Money Doing with ASTH?

Insider Signal

NEUTRAL

0 buys / 0 sells (90d)

Congress Signal

NEUTRAL

0 buys / 0 sells (90d)

Institutional

N/A

Short Squeeze Risk

HIGH

Signal: HIGH_SHORT_INTEREST

Recent Insider Activity

NameTitleTypeSharesValueDate
Vong JohnofficerSale642$20KNov 12, 2026
Sim BrandonofficerSale9,889$366KOct 6, 2026
Lam Thomas S.directorSale2,624$97KOct 6, 2026
Basho ChandanofficerSale2,092$75KOct 2, 2026
Kitayama Mitchell WdirectorSale8,500$315KAug 31, 2026
Schmidt DaviddirectorBuy4,525-Jun 10, 2026
Mazdyasni MatthewdirectorBuy4,525-Jun 10, 2026
Kitayama Mitchell WdirectorBuy4,991-Jun 10, 2026
Dong LindadirectorBuy4,525-Jun 10, 2026
Dai, WeilidirectorBuy4,525-Jun 10, 2026

Track Smart Money Across 4,000+ Stocks

Insider trades, congress trades, institutional flows, and short interest — updated daily with real-time alerts.

See Smart Money Data →

ASTH Growth Story

Revenue YoY

56.4%

3yr Revenue CAGR

40.6%

EPS Growth YoY

-48.89%

FCF Growth YoY

136.6%

Revenue Trend

ACCELERATING

Dark Pool Trades for ASTH

PREVIEW

Recent off-exchange (dark pool) prints for ASTH: size, dollar value and side. One of the data views on SEPT, alongside its own pressure bars, swings, volume spike levels and key levels.

TimePriceSizeValueSide
21:00:10$32.871,000$$33KSELL
18:59:49$32.882,000$$66KBUY
17:48:32$32.411,375$$45KBUY
16:12:16$32.361,100$$36KSELL
15:01:45$32.101,100$$35KSELL

5 dark pool trades shown · $$214K preview volume

Real-time institutional flow, block trades, and net positioning

See all dark pool activity

Full AI Research Report

SEPT's Trading AI has generated a free, downloadable PDF research report for Astrana Health, Inc. (ASTH) covering valuation analysis, financial health assessment, growth projections, smart money tracking, earnings and key price levels. For research only, not investment advice.

Report includes: PDF download, detailed valuation models (DCF, P/E, EV/EBITDA), institutional flow analysis, congress and insider trade tracking, FinBERT news sentiment (1 articles analyzed), and SEC filing intelligence...

Your strategy, tested before real money.

Describe your strategy in plain words. SEPT scans, alerts, backtests and paper trades it on its own market data. SEPT provides tools only and does not tell you what to buy or sell.

Try SEPT Free for 7 Days →

ASTH — frequently asked questions

What is ASTH stock price today?

Astrana Health, Inc. (ASTH) is at $32.53, down 1.03% (-$0.34) at the Nov 17, 2026 close.

Why is ASTH stock moving today?

Latest ASTH news — Nov 6, 2026: Needham keeps Buy rating on Astrana Health, lifts target to $45 · Nov 5, 2026: Astrana Health holds Q3 2026 earnings call

What is the ASTH price target?

The average analyst price target for ASTH is $51.50, ranging from $40 to $65, based on 8 analysts. Latest: Oppenheimer initiates on Sep 15, 2026.

What do analysts rate ASTH?

Analyst ratings for ASTH: 1 Buy, 12 Hold, 0 Sell — consensus Hold.

Did ASTH beat earnings?

ASTH last reported on Aug 6, 2026: EPS $0.40 vs $0.34 expected — a beat of 19.1%.

What is ASTH's P/E ratio?

ASTH trades at a P/E of 48.4 vs a Industrials average of 25.9.

Does ASTH pay a dividend?

Yes. ASTH's dividend yield is 0.65%.

What are ASTH support and resistance levels?

Support: $32.22, $29.33, $26.91. Resistance: $35.65, $38.77, $41.00.

What are insiders doing with ASTH?

Insider activity: NEUTRAL, 0 buys and 0 sells in the last 90 days.

What is the latest news on ASTH?

Nov 6, 2026: Needham keeps Buy rating on Astrana Health, lifts target to $45 · Nov 5, 2026: Astrana Health holds Q3 2026 earnings call